TY - JOUR
T1 - Lesion heterogeneity on high-field susceptibility MRI Is associated with multiple sclerosis severity
AU - Harrison, D. M.
AU - Li, X.
AU - Liu, H.
AU - Jones, C. K.
AU - Caffo, B.
AU - Calabresi, P. A.
AU - Van Zijl, P.
PY - 2016/8
Y1 - 2016/8
N2 - BACKGROUND AND PURPOSE: Susceptibility MR imaging contrast variations reflect alterations in brain iron and myelin content, making this imaging tool relevant to studies of multiple sclerosis lesion heterogeneity. In this study, we aimed to characterize the relationship of high-field, susceptibility contrasts in multiple sclerosis lesions to clinical outcomes. MATERIALSANDMETHODS: Twenty-four subjects with multiple sclerosis underwent 7TMRimaging of the brain, disability examinations, and a fatigue inventory. The inverse of T2relaxation time (R2), frequency, and relative susceptibility (from quantitative susceptibility mapping) were analyzed in 306 white matter lesions. RESULTS: Most lesions were hypointense on R2(88% without a rim, 5% with). Lesions that were hyperintense on quantitative susceptibility mapping were more frequent in relapsing-remitting than in progressive multiple sclerosis (54% versus 35%, P = .018). Hyperintense lesion rims on quantitative susceptibility maps were more common in progressive multiple sclerosis and patients with higher levels of disability and fatigue. Mean lesion R2was inversely related to disability and fatigue and significantly reduced in progressive multiple sclerosis. Relative susceptibility was lower in lesions in progressive multiple sclerosis (median,=0.018 ppm; range,-0.070 to 0.022) than in relapsing-remitting MS (median,-0.010 ppm; range,-0.062 to 0.052; P = .003). CONCLUSIONS: A progressive clinical phenotype and greater disability and fatigue were associated with lower R2and relative susceptibility values (suggestive of low iron due to oligodendrocyte loss) and rimmed lesions (suggestive of chronic inflammation) in this multiple sclerosis cohort. Lesion heterogeneity on susceptibility MR imaging may help explain disability in multiple sclerosis and provide a window into the processes of demyelination, oligodendrocyte loss, and chronic lesion inflammation.
AB - BACKGROUND AND PURPOSE: Susceptibility MR imaging contrast variations reflect alterations in brain iron and myelin content, making this imaging tool relevant to studies of multiple sclerosis lesion heterogeneity. In this study, we aimed to characterize the relationship of high-field, susceptibility contrasts in multiple sclerosis lesions to clinical outcomes. MATERIALSANDMETHODS: Twenty-four subjects with multiple sclerosis underwent 7TMRimaging of the brain, disability examinations, and a fatigue inventory. The inverse of T2relaxation time (R2), frequency, and relative susceptibility (from quantitative susceptibility mapping) were analyzed in 306 white matter lesions. RESULTS: Most lesions were hypointense on R2(88% without a rim, 5% with). Lesions that were hyperintense on quantitative susceptibility mapping were more frequent in relapsing-remitting than in progressive multiple sclerosis (54% versus 35%, P = .018). Hyperintense lesion rims on quantitative susceptibility maps were more common in progressive multiple sclerosis and patients with higher levels of disability and fatigue. Mean lesion R2was inversely related to disability and fatigue and significantly reduced in progressive multiple sclerosis. Relative susceptibility was lower in lesions in progressive multiple sclerosis (median,=0.018 ppm; range,-0.070 to 0.022) than in relapsing-remitting MS (median,-0.010 ppm; range,-0.062 to 0.052; P = .003). CONCLUSIONS: A progressive clinical phenotype and greater disability and fatigue were associated with lower R2and relative susceptibility values (suggestive of low iron due to oligodendrocyte loss) and rimmed lesions (suggestive of chronic inflammation) in this multiple sclerosis cohort. Lesion heterogeneity on susceptibility MR imaging may help explain disability in multiple sclerosis and provide a window into the processes of demyelination, oligodendrocyte loss, and chronic lesion inflammation.
UR - http://www.scopus.com/inward/record.url?scp=84982095818&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84982095818&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A4726
DO - 10.3174/ajnr.A4726
M3 - Article
C2 - 26939635
AN - SCOPUS:84982095818
SN - 0195-6108
VL - 37
SP - 1447
EP - 1453
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 8
ER -